Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
94 Cards in this Set
- Front
- Back
|
administer IV push slowly
|
min: furosemide
|
|
|
monitor for breath sounds
|
min.furosemide
|
|
|
more susceptible to rapid fluid/electrolyte loss
|
lifespan alert for older adults
|
|
|
hdchthzde pregnancy risk
|
B
|
|
|
furosemide pregnancy risk
|
C
|
|
|
Adv: electrolyte imbalance
|
mannitol
triamterene |
|
|
adv. fluid and electrolyte loss
|
furosemide
hydrochlorothiazide |
|
|
dizzy,vomit, naussea, vertigo
|
adv. effects of hydrochloroythizaide from fluid and electrolyte loss
|
|
|
adv. aplastic anemia
|
hydrochlorothiazide
|
|
|
K is reabsorbed
|
triamterene
|
|
|
A K sparing drug used to treat CHF
|
eplerenone
|
|
|
loop diuretic
|
furosemide
|
|
|
K sparing diuretic
|
triamterene
|
|
|
Pt. education: stress importance of periodic bloodwork
|
Hdchthzde
furosemide triamterene |
|
|
When giving diuretics, what are you concerned about when monitoring for weight gain?
|
edema
|
|
|
diuretics indicated for HTN and edema
|
hdchlthzde
furosemide triamterene |
|
|
thrombocytopenia (non-life-threatening serious adv)
|
hdchlthzde
|
|
|
nausea, vomit, anorexia, headache, dry mouth
|
adv effect for triamterene
|
|
|
increased BUN, increased serum creatinine
|
hdchlthzde
furosemide triamterene |
|
|
supplement K in diet if levels fall below
|
3.0-3.5
|
|
|
Max: warm drug vial in H2O, no warmer than body temp, to see if crystals form
|
mannitol
|
|
|
need K rich foods
|
furosemide
hctz |
|
|
htcz is contraindicated in severe renal disease b/c
|
it decreases gfr
|
|
|
works in the loop of henle
|
furosemide
|
|
|
diuretic indicated 4 hepatic and renal disease
|
furosemide
|
|
|
furosemide onset
|
PO 1 hr
iv 5 min |
|
|
Ser. adv. worsening of CHF
|
mannitol
|
|
|
Adv. dry mouth, headache
|
tolteridine
|
|
|
treats acute renal failure
|
mannitol
|
|
|
contr: anuria in CRF
|
furosemide & hctz
|
|
|
like hctz, furosemide excretes
|
na, k, Cl, h2o
|
|
|
diuretic indicated for CHF and CRF
|
furosemide
|
|
|
Min. decrease dosage if pt has renal or liver disease
|
tolteridine
|
|
|
decreased calcium
increased risk for hip fracture |
furosemide
|
|
|
mannitol onset
|
0.5-1 hour IV
|
|
|
freely filtered, but not reabsorbed, therefore causes diuresis
|
mannitol
|
|
|
95% bound to plasma proteins
|
furosemide
|
|
|
serious adv. effects : serious fluid/electrolyte imbalance
|
triamterene, mannitol
|
|
|
blocks muscarinic recptors so bladder contraction cannot occur
|
tolteridine
|
|
|
most electrolyte loss occurs in first 2 weeks
|
furosemide, hctz
|
|
|
serious adv.: onset or exacerbation of SLE
|
furosemide
|
|
|
prototype anticholinergic agent affecting urinary output
|
tolteridine
|
|
|
works better on African Americans than on Europeans
|
hctz for HTN
|
|
|
Contra: already using K sparing diuretics
|
triamterene
|
|
|
Life span: _________are especially at risk for hyperkalemia
|
older adults
|
|
|
safety alert: life-threatening hyperkalemia when ____ & ____ or ____ are coadministered
|
triamterene
K supplements drugs increasing K |
|
|
adv. hypocalcemia
|
furosemide
|
|
|
imp pt edu: triamterene
|
avoid K rich foods
no k supplements no salt substitutes |
|
|
prototype osmotic diuretic
|
mannitol
|
|
|
control urinary frequency, urgency or urge incontinence
|
tolteridine
|
|
|
adv. ototoxicity
|
furosemide
|
|
|
tolteridine onset
|
IR 1 week
|
|
|
Min adv.monitor serum electrolytes
|
hctz
furosemide triamterene |
|
|
Contr: urinary and gastric retention
|
tolterodine
|
|
|
structurally similar to antibacterial sulfonomide
|
hctz
|
|
|
promotes na and h2o secretion
|
triamterene
|
|
|
monitor bp, weight gain and I & O
|
furosemide, hctz , triamterene
|
|
|
weight gain
|
about 3 lbs. /day, indicating edema
|
|
|
onset triamterene
|
PO 2-4 hours
|
|
|
hctz/anticoagulant interaction
|
decreases anticoagulant activity. monitor prothrombin time, lower dose if necessary
|
|
|
SLE
|
systemic lupus erythematosus
|
|
|
"high ceiling" diuretic
|
furosemide
|
|
|
excretes Na, K cl and h2o
|
furosemide , hctz
|
|
|
remember: for every diuretic
|
EZ access to toilet
give in the morning |
|
|
___is the 1st choice diuretic for treating HTN with ___b/c it does not
|
furosemide
pre-existing renal disease decrease gfr |
|
|
serious adv. effects:
obscure or worsened hypovolemia |
mannitol
|
|
|
Pt. edu: tolterodine
report urinary retention, gastric retention, or |
blurred vision
|
|
|
Mannitol: Min.
give a test dose to people with |
oliguria or
inadequate renal function |
|
|
If urine output does not increase after _____ of mannitol, discontinue
|
2 test doses
|
|
|
most common adverse effects of triamterene: nausea, vomit, anorexia, ___ ___
|
headache
dry mouth |
|
|
Mannitol is a ___that draws h2o into the ____ through____
|
sugar
vascular space osmosis |
|
|
contrain: uncontrolled narrow angle glaucoma
|
tolterodine
|
|
|
diuretic that can increase blood glucose
|
hctz furosemide
|
|
|
works in the distal tubule
|
hctz
|
|
|
treats increased intracranial pressure
|
mannitol
|
|
|
ser. adv: hyperkalemia
|
triamterene
|
|
|
will decrease bladder function
|
tolterodine
|
|
|
contr: intracranial bleed
|
mannitol
|
|
|
contr: severe renal disease anuria
|
hctz
furosemide triamterene mannitol |
|
|
ace inhibitor/hctz interaction
|
increased postural hypotension
|
|
|
longterm increased bone density decreased risk of fracture
|
hctz
|
|
|
decreased urinary secretion of Ca
|
hctz
|
|
|
highly protein bound
|
hctz
|
|
|
contr: pulmonary edema
|
mannitol
|
|
|
serious adv. significant hypoK
|
furosemide
|
|
|
treats increased intraocular pressure
|
mannitol
|
|
|
permanent deafness
|
furosemide
|
|
|
diuretic indicated for pulmonary edema
|
furosemide
|
|
|
triamterene P risk
|
C
|
|
|
contr: uncontrolled narrow angle glaucoma
|
tolterodine
|
|
|
Mannitol P risk
|
C
|
|
|
hypercalcemia
|
hctz
|
|
|
used in combo with other diuretics to reduce K loss
|
triamterene
|
|
|
most common adverese effects: dizzy GI problems
|
mannitol
|
